Nanotechnology Now - Press Release: "Nanotech particles affect brain development in mice"

Home > Press > Nanotech particles affect brain development in mice

Abstract:
Maternal exposure to nanoparticles of titanium dioxide (TiO2) affects the expression of genes related to the central nervous system in developing mice.

Nanotech particles affect brain development in mice

Tokyo | Posted on July 29th, 2009

Researchers writing in BioMed Central's open access journal Particle and Fibre Toxicology found that mice whose mothers were injected with the nanoparticles while pregnant showed alteration in gene expression related to neurological dysfunction.

Ken Takeda led a team of researchers from the Tokyo University of Science, Japan, who carried out the tests. He said, "Nanotechnology and the production of novel man-made nanoparticles are increasing worldwide. Titanium dioxide in its nanoparticle form has a high level of photocatalytic activity, and can be used for air and water purification and self-cleaning surfaces. Our findings, however, add to the current concern that this specific nanomaterial may have the potential to affect human health".

For this study, the researchers injected pregnant mice with Ti02 nanoparticles. The brains were obtained from male fetuses/pups on the 16th day of gestation and at several points after birth. Comparing these brains to those of control animals, the researchers were able to demonstrate changes in expression of hundreds of genes. According to Takeda, "Diseases associated with these genes include those we normally consider to develop in childhood, such as autistic disorder, epilepsy and learning disorders, and also others that arise mainly in adulthood or old age, such as Alzheimer's disease, schizophrenia and Parkinson's disease."

Nanotechnology deals with engineering at the molecular scale. Materials reduced to nanoparticles behave in ways dissimilar to those we're used to - altering their reactivity, surface area to volume and any number of other properties. While larger TiO2 particles are commonly used in paints and sunblocks, nanoparticles of TiO2 are specially created for new applications in coatings and self-cleaning surfaces and their effects on living tissue are only beginning to be understood. It should be noted that this gene expression data cannot be interpreted as a direct health effect. In addition, the nanoparticles were deliberately injected at a high dose, so the relevance to real-life exposure may be limited.

Notes to Editors

Maternal exposure to nanoparticulate titanium dioxide during the prenatal period alters gene expression related to brain development in the mouse Midori Shimizu, Hitoshi Tainaka, Taro Oba, Keisuke Mizuo, Masakazu Umezawa and Ken Takeda Particle and Fibre Toxicology (in press)

During embargo, article available here: www.particleandfibretoxicology.com/imedia/2087106473265705_article.pdf?random=52984 After the embargo, article available at journal website: www.particleandfibretoxicology.com/

Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.

Article citation and URL available on request at on the day of publication

Particle and Fibre Toxicology is an open access, peer-reviewed, online journal for new scientific data, hypotheses and reviews on the toxicological effects of particles and fibres; it functions as a forum for scientific debate and communication between toxicology and disciplines that develop (nano)particles for future applications. These include material sciences, and applications in nanomedicine, such as drug delivery and imaging.

BioMed Central (www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.

####

About BioMed Central
BioMed Central is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model

All original research articles published by BioMed Central are made freely and permanently accessible online immediately upon publication. BioMed Central views open access to research as essential in order to ensure the rapid and efficient communication of research findings.

For more information, please click here

Contacts:
Graeme Baldwin

44-020-319-22165

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: